ACTA1 and systemic sclerosis: At protein level, in SSc fibrocytes both concentrations of nintedanib significantly reduced the synthesis of αSMA, S100A4, COL1, and FN primarily after 24 h of treatment compared to untreated fibrocytes (p < 0.05 for all proteins for both concentrations) (Fig. 3B).